vTv Therapeutics and OnKure part ways, dissolving pivotal cellular drug agreement

vTv Therapeutics, a clinical-stage biopharmaceutical company known for its innovative approach in diabetes treatment, and OnKure Therapeutics, an oncology-focused pharmaceutical company, have announced the termination ... Read More